4/A//SEC Filing
Carter Robert Ross 4/A
Accession 0001079973-26-000039
CIK 0001799191other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:30 PM ET
Size
5.2 KB
Accession
0001079973-26-000039
Insider Transaction Report
Form 4/AAmended
Carter Robert Ross
Chief Financial Officer
Transactions
- Other
Common Stock
2026-01-02$3.67/sh−244$895→ 235,125 total
Footnotes (1)
- [F1]The Issuer executed the sale to cover the tax liabilities arising from the vesting of an RSU award on January 1, 2026.
Documents
Issuer
Oncology Institute, Inc.
CIK 0001799191
Entity typeother
Related Parties
1- filerCIK 0002039341
Filing Metadata
- Form type
- 4/A
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 4:30 PM ET
- Size
- 5.2 KB